Can-Fite BioPharma Ltd. (CANF) is a novel biotechnology company. The company produces drugs used in cancer, and liver, treatment. The pipeline candidate of the company
On Wednesday, Can-Fite BioPharma Ltd. (CANF) announced filing new patent applications in various countries based on new clinical data. The company is filing applications for
Can Fite Biopharma Inc. (NASDAQ: CANF) stock showed a 3.03% gain during the last trading close while the stock is showing a hike of 77.94%
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.